Zenas BioPharma, Inc. (ZBIO) Executive Compensation
Zenas BioPharma, Inc. (ZBIO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ZBIO
CIK: 1953926
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerChristopher Pereira
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-13 | 2026-10-12 | FORM 8-K | 0001104659-26-115151 | View SEC Doc Filr Page |
| S-3ASR | 2026-09-11 | — | S-3ASR | 0001104659-26-107108 | View SEC Doc Filr Page |
| S-8 | 2026-09-11 | — | FORM S-8 | 0001104659-26-107105 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-08 | — | SCHEDULE 13G Filing | 0000902219-26-000315 | View SEC Doc Filr Page |
| 3 | 2026-09-08 | 2026-08-26 | 3 Filing | 0001213900-26-097827 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-08 | — | SCHEDULE 13G/A Filing | 0001213900-26-097825 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | OWNERSHIP DOCUMENT | 0001104659-26-104728 | View SEC Doc Filr Page |
| 3 | 2026-09-02 | 2026-09-01 | OWNERSHIP DOCUMENT | 0001104659-26-104726 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-19 | — | SCHEDULE 13D/A Filing | 0001953107-26-000015 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001968582-26-000858 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-17 | — | SCHEDULE 13D/A Filing | 0001072613-26-000694 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001104659-26-095448 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-12 | FORM 8-K | 0001104659-26-095437 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 | 0001193125-26-274473 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075257 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075256 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075255 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075254 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075253 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075252 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075251 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075250 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | OWNERSHIP DOCUMENT | 0001104659-26-075249 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-18 | OWNERSHIP DOCUMENT | 0001104659-26-063362 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001104659-26-059735 | View SEC Doc Filr Page |